author-photo

Gustavo A. Fonseca

University of Texas MD Anderson Cancer Center

13

Papers

248

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

System Architecture of a Robotics Airship

2021
Show All
- Source
- Cite
- Save
Citations (1)
Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial

2020 Blood
Show All
- Source
- Cite
- Save
Citations (3)
A health-related quality-of-life (HRQoL) analysis of pomalidomide + low-dose dexamethasone + daratumumab in relapsed refractory multiple myeloma (RRMM) after lenalidomide treatment.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Pomalidomide (POM) + low-dose dexamethasone (LoDEX) + daratumumab (DARA) in relapsed and/or refractory multiple myeloma (RRMM) after lenalidomide (LEN)-based treatment (Tx) failure.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A randomized, multicenter, phase (Ph) III study comparing carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (Dex) to LEN and Dex in patients (Pts) with relapsed multiple myeloma (MM).

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (21)
Strategies to reduce side effects of interleukin-2: evaluation of the antihypotensive agent NG-monomethyl-L-arginine.

2000 The cancer journal from Scientific American
Show All
- Source
- Cite
- Save
Citations (24)
Phase II Trial of Liposome-Encapsulated Doxorubicin, Cyclophosphamide, and Fluorouracil as First-Line Therapy in Patients With Metastatic Breast Cancer

1999 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (78)
Fine-Needle Aspiration Cytology of Mediastinal Non-Hodgkin's Nonlymphoblastic Lymphoma

1998 Cancer
Show All
- Source
- Cite
- Save
Citations (26)
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension

1995 Critical Care Medicine
Show All
- Source
- Cite
- Save
Citations (58)